Evoke Pharma, Inc. announced that on February 8, 2023, the Board of Directors of the company appointed Matthew J. D'Onofrio, the Company's Executive Vice President and Chief Business Officer, to the positions of President and Chief Operating Officer, effective as of February 8, 2023. Mr. D'Onofrio continues to serve as the Company's Treasurer and Secretary. Mr. D'Onofrio, 53, is one of the Company's co-founders.

Prior to his promotion, Mr. D'Onofrio had served as the Company's Executive Vice President, Chief Business Officer, Secretary and Treasurer since 2010 and previously served as the Company's Executive Vice President, Corporate Development, Secretary and Treasurer from 2007 to 2010. Mr. D'Onofrio has over 30 years of experience in both large and small pharmaceutical firms. Prior to founding Evoke, Mr. D'Onofrio was Vice President, Business Development for Victory Pharma. Mr. D'Onofrio was previously Director and Head of West Coast Business Development at Vertex Pharmaceuticals, Incorporated, directing partnership efforts associated with the La Jolla research facility as well as other corporate assets.

Mr. D'Onofrio also held various commercial roles of increasing responsibility over a decade at Eli Lilly & Company, including significant experience in worldwide corporate business development. Mr. D'Onofrio earned a B.S. in Chemistry from San Diego State University and an M.B.A. from the University of Southern California. In connection with Mr. D'Onofrio's promotion, David A. Gonyer, R.Ph., resigned from the position of President, effective as of February 8, 2023.

Mr. Gonyer continues to serve as the Company's Chief Executive Officer.